Chlamydia vaccine shows promise in initial trials
HQ Team April 12, 2024: An early-stage clinical trial for a chlamydia vaccine has shown some positive results, according to a report published.
Drugs
Health
Medical
Climate
Health
Medical
Study maps US, China, Australia as hotspots for āforever chemicalsā in water supplies
HQ Team April 10, 2024: Ā The Environmental Protection Agency in the US has regulated for the first time that municipal utilities will have.
Climate
Health
Medical
57 companies responsible for 80% of recent world carbon emissions, says report
HQ Team April 10, 2024: A report released by the international non-profitĀ InfluenceMapĀ reveals that just 57 companies are responsible for 80 percent of the.
Drugs
Health
Pharma
Rivalling Elon Muskās Neurolink, Synchron plans brain implant trialĀ
HQ Team April 9, 2024: Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with.
Drugs
Health
Pharma
Last-stage trials achieve āpositiveā results for RSV drug: Pfizer says
HQ Team April 9, 2024: Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to.
Drugs
Health
Medical
Oral spray vaccine offers long-term relief against recurrent UTIs
HQ Team April 8, 2024: An oral spray vaccine has proved effective in halting recurrent Urinary Tract Infections (UTIs) for up to nine.
Drugs
Health
Medical
Rapid cellular aging reason behind early-onset cancers: Scientists
HQ Team April 8, 2024: More cancer cases are being detected among the younger generation, according to a new study presented at the.
Climate
Health
Pharma
PFAS found in leading brands of bandages, says report
HQ Team April 8, 2024: A study commissioned by the Environmental Health News and consumer watchdog site Mamavation, found that many bandage brands.
Drugs
Health
Pharma
Amylyx Pharma pulls out ALS therapy drug from US, Canada
HQ Team April 4, 2024: Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the.
Drugs
Health
Pharma
Britainās CMA raises concern over Theramexās Femoston buy
HQ Team April 4, 2024: Britainās Competition and Markets Authority (CMA) expressed concerns over Theramex’s planned acquisition of Femoston and Duphaston stating it.